Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia
Thyroid Diseases
About this trial
This is an interventional treatment trial for Thyroid Diseases focused on measuring topical bupivacaine, awake extubation, thyroidectomy, general anesthesia
Eligibility Criteria
Inclusion Criteria:
Patient acceptance. BMI < 35kg/m2. ASA I and ASA II. Scheduled for elective thyroidectomy under general anesthesia
Exclusion Criteria:
Patient refusal. History or anticipated difficult intubation. Chronic respiratory disease such as chronic obstructive pulmonary disease or asthma.
Recent respiratory tract infection in the last month, chronic cough, and current smoking.
History of laryngeal or tracheal surgery or pathology. Patients with symptomatic gastric reflux. Patients with a known history of allergy to study drugs.
Sites / Locations
- Faculty of medicine, zagazig university
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Control group
bupivacaine group
patients will receive 5ml of normal saline 0.9% topically 15 min before the expected end of surgery.
patients will receive 5ml of bupivacaine 0.5% topically 15 min before the expected end of surgery.